Maze Therapeutics Inc
NASDAQ:MAZE
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
M
|
Maze Therapeutics Inc
NASDAQ:MAZE
|
US |
|
T
|
Tapestry Inc
DUS:COY
|
US |
|
Cleantech Vanadium Mining Corp
XTSX:CTV
|
CA |
|
A
|
Avex Inc
XMUN:AX8
|
JP |
|
C
|
CECO Environmental Corp
F:WCE
|
US |
|
P
|
Pacific & Orient Bhd
KLSE:P&O
|
MY |
|
Wyndham Hotels & Resorts Inc
LSE:0YTR
|
US |
|
S
|
Stantec Inc
F:S3A
|
CA |
Wall St Price Targets
MAZE Price Targets Summary
Maze Therapeutics Inc
According to Wall Street analysts, the average 1-year price target for MAZE is 56.61 USD with a low forecast of 46.46 USD and a high forecast of 115.5 USD.
Price Targets
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
What is MAZE's stock price target?
Price Target
56.61
USD
According to Wall Street analysts, the average 1-year price target for MAZE is 56.61 USD with a low forecast of 46.46 USD and a high forecast of 115.5 USD.